Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01615939Phase 4Terminated
A Phase 4 trial of ropivacaine in Foot fracture, sponsored by Northwestern University. Started Jun 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01615939.